Baron Health Care Fund
Baron Health Care Fund reported 49 holdings worth US$114M as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Aug 28, 2026
Baron Health Care Fund reported 49 holdings worth US$114M as of Jun 30, 2026. Largest: Eli Lilly And Company, Mettler-toledo International, Inc. and Johnson & Johnson. Filed Aug 28, 2026 (Form N-PORT).
- Holdings
- 49
- Value as reported
- US$114M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 13,000 | US$15.6M | 13.7% |
| Mettler-toledo International, Inc. | 5,000 | US$6.39M | 5.6% |
| Johnson & Johnson | 25,000 | US$6.35M | 5.6% |
| Argenx Se | 5,200 | US$4.82M | 4.2% |
| Thermo Fisher Scientific Inc | 8,900 | US$4.46M | 3.9% |
| Roivant Sciences Ltd. | 125K | US$4.42M | 3.9% |
| Teva Pharmaceutical Industries Limited | 130K | US$4.4M | 3.9% |
| Welltower Inc. | 17,000 | US$3.86M | 3.4% |
| Unitedhealth Group Incorporated | 9,000 | US$3.74M | 3.3% |
| Radnet, Inc. | 60,000 | US$3.7M | 3.2% |
| Billiontoone, Inc. | 27,000 | US$3.24M | 2.8% |
| Edwards Lifesciences Corporation | 33,300 | US$3.01M | 2.6% |
| Vertex Pharmaceuticals Incorporated | 6,000 | US$2.98M | 2.6% |
| Astrazeneca Plc | 15,000 | US$2.84M | 2.5% |
| Merck & Company, Inc. | 22,000 | US$2.83M | 2.5% |
| Guardant Health, Inc. | 16,500 | US$2.48M | 2.2% |
| Madrigal Pharmaceuticals, Inc. | 4,500 | US$2.42M | 2.1% |
| Revolution Medicines, Inc. | 12,500 | US$2.34M | 2.1% |
| Elanco Animal Health Incorporated | 95,000 | US$2.34M | 2.0% |
| Kymera Therapeutics, Inc. | 20,000 | US$2.29M | 2.0% |
| Gilead Sciences, Inc. | 18,000 | US$2.27M | 2.0% |
| Natera, Inc. | 8,100 | US$2.2M | 1.9% |
| Intuitive Surgical, Inc. | 5,000 | US$1.99M | 1.7% |
| Protagonist Therapeutics, Inc. | 16,000 | US$1.96M | 1.7% |
| Elevance Health, Inc. | 5,000 | US$1.93M | 1.7% |
| Repligen Corporation | 12,500 | US$1.71M | 1.5% |
| Xenon Pharmaceuticals Inc. | 25,000 | US$1.51M | 1.3% |
| Heartflow, Inc. | 48,848 | US$1.43M | 1.3% |
| Ionis Pharmaceuticals, Inc. | 18,000 | US$1.43M | 1.3% |
| Idexx Laboratories, Inc. | 2,600 | US$1.37M | 1.2% |
| Dexcom, Inc. | 20,000 | US$1.35M | 1.2% |
| Veradermics, Incorporated | 10,000 | US$1.23M | 1.1% |
| Insmed Incorporated | 10,000 | US$1.07M | 0.93% |
| Arcutis Biotherapeutics, Inc. | 35,000 | US$918K | 0.80% |
| Sartorius Stedim Biotech Sa | 4,000 | US$829K | 0.73% |
| Axsome Therapeutics, Inc. | 3,000 | US$734K | 0.64% |
| Cytokinetics, Incorporated | 8,500 | US$724K | 0.63% |
| Definium Therapeutics, Inc. | 13,855 | US$652K | 0.57% |
| Ascendis Pharma A/s | 1,500 | US$400K | 0.35% |
| Tango Therapeutics, Inc. | 12,500 | US$391K | 0.34% |
| Abivax Sa | 2,500 | US$333K | 0.29% |
| Newamsterdam Pharma Company N.v. | 9,000 | US$305K | 0.27% |
| Enliven Therapeutics, Inc. | 5,000 | US$254K | 0.22% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Abbvie Inc. | 0 | US$0 | 0.00% |
| Insulet Corporation | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Stryker Corporation | 0 | US$0 | 0.00% |
| Medline Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related